Top Markets
Coin of the day
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Classement en actions #25524
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Prix de l'action
$9.81
Dernière synchronisation: 2025-03-18
Capitalisation boursière
$48.68M
Changement (1 jour)
1.55%
Changement (1 an)
0.00%
Pays
US
Échange AlloVir, Inc. (ALVR)

Catégorie

EPS pour AlloVir, Inc. (ALVR)
EPS au June 2026 TTM : $-1.71
Selon les derniers rapports financiers et le cours de l'action de AlloVir, Inc., l’EPS actuel de la société (TTM) est de $-1.71. À la fin de 2023, la société avait un EPS de $-42.09 une diminution par rapport à celui de 2022, qui était de $-50.60.
Historique de l'EPS de AlloVir, Inc. de 2018 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-1.71 -85.42%
2024 $-11.73 -72.13%
2023 $-42.09 -16.82%
2022 $-50.60 -19.71%
2021 $-63.02 5.79%
2020 $-59.57 354.39%
2019 $-13.11 71,150.00%
2018 $-0.02 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -1,112.87%
US
$27.74 -1,722.22%
NL
$2.98 -274.27%
AU
- -
CH
$-7.98 366.67%
US